**** SECTION 2 - COMPOSITION, INFORMATION ON INGREDIENTS ****
+----------------+--------------------------------------+----------+-----------+
| CAS# | Chemical Name | % | EINECS# |
|----------------|--------------------------------------|----------|-----------|
| 3006-93-7 |N,N'-m-Phenylenedimaleimide | | 221-112-8 |
+----------------+--------------------------------------+----------+-----------+
Hazard Symbols: T+
Risk Phrases: 22 26 36/37/38
**** SECTION 3 - HAZARDS IDENTIFICATION ****
EMERGENCY OVERVIEW
Harmful if swallowed. Very toxic by inhalation. Irritating to eyes,
respiratory system and skin.
Potential Health Effects
Eye:
Causes eye irritation.
Skin:
Causes skin irritation. May be harmful if absorbed through the skin.
Ingestion:
Harmful if swallowed. May cause irritation of the digestive tract.
Inhalation:
May be fatal if inhaled. Causes respiratory tract irritation.
Chronic:
Not available.
**** SECTION 4 - FIRST AID MEASURES ****
Eyes:
Immediately flush eyes with plenty of water for at least 15 minutes,
occasionally lifting the upper and lower eyelids. Get medical aid
immediately.
Skin:
Get medical aid immediately. Immediately flush skin with plenty of
water for at least 15 minutes while removing contaminated clothing
and shoes.
Ingestion:
Get medical aid immediately. Wash mouth out with water.
Inhalation:
Get medical aid immediately. Remove from exposure and move to fresh
air immediately. If not breathing, give artificial respiration. If
breathing is difficult, give oxygen.
Notes to Physician:
**** SECTION 5 - FIRE FIGHTING MEASURES ****
General Information:
As in any fire, wear a self-contained breathing apparatus in
pressure-demand, MSHA/NIOSH (approved or equivalent), and full
protective gear.
Extinguishing Media:
Use foam, dry chemical, or carbon dioxide.
**** SECTION 6 - ACCIDENTAL RELEASE MEASURES ****
General Information: Use proper personal protective equipment as indicated
in Section 8.
Spills/Leaks:
Vacuum or sweep up material and place into a suitable disposal
container.
**** SECTION 7 - HANDLING and STORAGE ****
Handling:
Do not breathe dust, vapor, mist, or gas. Do not get in eyes, on
skin, or on clothing. Use only in a chemical fume hood.
Storage:
Store in a cool, dry place. Store in a tightly closed container.
Poison room locked.
**** SECTION 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION ****
Engineering Controls:
Facilities storing or utilizing this material should be equipped
with an eyewash facility and a safety shower. Use adequate
ventilation to keep airborne concentrations low.
Exposure Limits
CAS# 3006-93-7:
Russia: 1 mg/m3 TWA
Personal Protective Equipment
Eyes:
Not available.
Skin:
Wear appropriate protective gloves to prevent skin
exposure.
Clothing:
Wear appropriate protective clothing to prevent skin
exposure.
Respirators:
Follow the OSHA respirator regulations found in 29
CFR 1910.134 or European Standard EN 149. Use a
NIOSH/MSHA or European Standard EN 149 approved
respirator if exposure limits are exceeded or if
irritation or other symptoms are experienced.
**** SECTION 9 - PHYSICAL AND CHEMICAL PROPERTIES ****
Physical State: Powder
Color: yellow - light brown
Odor: odorless
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: Not available.
Freezing/Melting Point: > 204 deg C
Autoignition Temperature: Not available.
Flash Point: Not available.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature:
Solubility in water: Negligible.
Specific Gravity/Density:
Molecular Formula: C14H8N2O4
Molecular Weight: 268.23
**** SECTION 10 - STABILITY AND REACTIVITY ****
Chemical Stability:
Stable under normal temperatures and pressures.
Conditions to Avoid:
Incompatible materials.
Incompatibilities with Other Materials:
Strong oxidizing agents.
Hazardous Decomposition Products:
Nitrogen oxides, carbon monoxide, carbon dioxide.
Hazardous Polymerization: Will not occur.
**** SECTION 11 - TOXICOLOGICAL INFORMATION ****
RTECS#:
CAS# 3006-93-7: ON6125000
LD50/LC50:
CAS# 3006-93-7: Inhalation, rat: LC50 = 55 mg/m3/4H; Oral, mouse:
LD50 = 250 mg/kg; Oral, rat: LD50 = 1370 mg/kg.
Carcinogenicity:
N,N'-m-Phenylenedimaleimide -
Not listed by ACGIH, IARC, or NTP.
Other:
See actual entry in RTECS for complete information.
**** SECTION 12 - ECOLOGICAL INFORMATION ****
**** SECTION 13 - DISPOSAL CONSIDERATIONS ****
Dispose of in a manner consistent with federal, state, and local regulations.
**** SECTION 14 - TRANSPORT INFORMATION ****
IATA
No information available.
IMO
No information available.
RID/ADR
No information available.
**** SECTION 15 - REGULATORY INFORMATION ****
European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: T+
Risk Phrases:
R 22 Harmful if swallowed.
R 26 Very toxic by inhalation.
R 36/37/38 Irritating to eyes, respiratory system
and skin.
Safety Phrases:
S 28A After contact with skin, wash immediately with
plenty of water.
S 36/37/39 Wear suitable protective clothing, gloves
and eye/face protection.
S 38 In case of insufficient ventilation, wear
suitable respiratory equipment.
S 45 In case of accident or if you feel unwell, seek
medical advice immediately (show the label where
possible).
WGK (Water Danger/Protection)
CAS# 3006-93-7: No information available.
Canada
CAS# 3006-93-7 is listed on Canada's DSL List.
CAS# 3006-93-7 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 3006-93-7 is listed on the TSCA inventory.
**** SECTION 16 - ADDITIONAL INFORMATION ****
MSDS Creation Date: 7/13/2000 Revision #1 Date: 3/18/2003
The information above is believed to be accurate and represents the best
information currently available to us. However, we make no warranty of
merchantability or any other warranty, express or implied, with respect to
such information, and we assume no liability resulting from its use. Users
should make their own investigations to determine the suitability of the
information for their particular purposes. In no way shall the company be
liable for any claims, losses, or damages of any third party or for lost
profits or any special, indirect, incidental, consequential or exemplary
damages, howsoever arising, even if the company has been advised of
the possibility of such damages.
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
|
|
|
| ALL MSDS PAGES IN THIS GROUP
| | NAME | CAS |
|
Methyl 4-amino-3-bromobenzoate
| 106896-49-5 |
|
2,4-Dichloro-5-hydroxyaniline
| 39489-79-7 |
|
6-Chloro-4-trifluoromethoxyaniline
| 0-01-1 |
|
2,4-Dibromo-6-methylaniline
| 30273-41-7 |
|
1,4-Bis(trichloromethyl)benzene, 99%
| 68-36-0 |
|
Nicotinamide, p.a.
| 98-92-0 |
|
6-Chloro-9-(3-N-(2-chloroethyl-amino)-propylamino-2-methoxyacridine
| 17064-47-0 |
|
2-Amino-5-bromobenzotrifluoride
| 445-02-3 |
|
N,N'-p-Phenylenedimaleimide
| 3278-31-7 |
|
N,N'-m-Phenylenedimaleimide
| 3006-93-7 |
|
Allyltrimethylsilane, 97%
| 762-72-1 |
|
Celite 545
| 68855-54-9 |
|
3-Bromo-1-propanol, 97%
| 627-18-9 |
|
1,2-Epoxy-2-methylbutane
| 30095-63-7 |
|
2,3-Epoxy-2-methylbutane
| 5076-19-7 |
|
Dicyclopentadiene diepoxide
| 81-21-0 |
|
1-(3-Methylphenyl)-piperazine, 99%
| 41186-03-2 |
|
Lithium bis(trimethylsilyl)amide, 23% in methyl tert-butyl ether
| 100-41-4 |
|
Lithium bis(trimethylsilyl)amide, 20% in THF
| 100-41-4 |
|
2(2-Bromoethyl)-1,3-dioxolane, 96%
| 18742-02-4 |
|
N-(Phenylseleno)phthalimide, tech.
| 71098-88-9 |
|
Brij?? 98
| 9004-98-2 |
|
4-Fluoro-N-methylaniline
| 459-59-6 |
|
3,4,5-Trimethoxyacetophenone, 99+%
| 1136-86-3 |
|
Potassium tetracyanonickelate(II) hydrate
| 14220-17-8 |
|
Zinc peroxide, 55%
| 1314-22-3 |
|
3,4-Dimethyl-3,4-diphenylhexane
| 10192-93-5 |
|
1,4-Naphthalenediol (pract), 95% (uv-vis)
| 571-60-8 |
|
2,3-Dimethyl-2,3-diphenylbutane
| 1889-67-4 |
|
Dicumyl peroxide
| 80-43-3 |
|
Cumyl hydroperoxide
| 80-15-9 |
|
tert-Butyl cumyl peroxide
| 98-82-8 |
|
3,6,9-Triethyl-3,6,9-trimethyl-1,4,7-triperoxynonane, 41% solution in
| 24748-23-0 |
|
Di(tert-butylperoxyisopropyl)benzene
| 2212-81-9 |
|
tert-Butyl peroxy-3,5,5-trimethylhexanoate
| 13122-18-4 |
|
tert-Butylperoxy 2-ethylhexyl carbonate
| 34443-12-4 |
|
Di-tert-butyl peroxide
| 110-05-4 |
|
1,1-Di(tert-butylperoxy)cyclohexane, 50% solution in aromatic free
| 3006-86-8 |
|
Lauroyl peroxide
| 105-74-8 |
|
tert-Butyl peroxyacetate, 50% solution in aromatic free mineral
| 107-71-1 |
|
2,5-Dimethyl-2,5-di(tert-butylperoxy)hexane
| 78-63-7 |
|
2,2-Di(tert-butylperoxy)butane, 50% solution in aromatic free mineral
| 78-93-3 |
|
Benzoylformic acid, 97%
| 611-73-4 |
|
Ethyl 7-bromoheptanoate
| 29823-18-5 |
|
16-Hydroxyhexadecanoic Acid, 98%
| 506-13-8 |
|
4-(4,6-Dimethoxy[1.3.5]triazin-2-yl)-4-methylmorpholinium chloride
| 0-00-0 |
|
3-Methoxysalicylic acid, 97%
| 877-22-5 |
|
d-alpha-Tocopherylquinone, 90-95%
| 7559-04-8 |
|
Dibutyl Maleate
| 105-76-0 |
|
Glutathione-Agarose, 4% cross-linked
| 0-01-1 |
|
|